Enhanced PI3K p110 Signaling Confers Acquired Lapatinib Resistance That Can Be Effectively Reversed by a p110 -Selective PI3K Inhibitor

出版年份 2013 全文链接

标题

作者

关键词

出版物

MOLECULAR CANCER THERAPEUTICS

Volume 13, Issue 1, Pages 60-70

出版商

American Association for Cancer Research (AACR)

发表日期

2013-11-19

DOI

10.1158/1535-7163.mct-13-0518

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

MOLECULAR CANCER THERAPEUTICS

向作者/读者发起求助以获取更多资源

Protocol

Reagent

Reprint

Discover Peeref hubs

Publish scientific posters with Peeref